Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 6/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.33 |
| ▸ | CDK2 | P24941 | 2/20 | 0.33 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.31 |
| ▸ | JAK2 | O60674 | 1/20 | 0.30 |
| ▸ | TYK2 | P29597 | 1/20 | 0.30 |
| ▸ | RAF1 | P04049 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23994980 | 1.00 | NT5E (0.37) | NT5EALDH1A1CCNE1CDK2CCNE2 | |
| SCHEMBL23993759 | 1.00 | NT5E (0.37) | NT5EALDH1A1CCNE1CDK2CCNE2 | |
| SCHEMBL23995523 | 1.00 | NT5E (0.37) | NT5EALDH1A1CCNE1CDK2CCNE2 | |
| SCHEMBL24514914 | 0.87 | NT5E (0.41) | NT5EALDH1A1CCNE1CDK2 | |
| SCHEMBL29614433 | 0.82 | NT5E (0.41) | NT5EALDH1A1CCNE1CDK2RAF1 | |
| SCHEMBL23994920 | 0.81 | NT5E (0.37) | NT5EALDH1A1CCNE1CDK2 | |
| SCHEMBL23993670 | 0.81 | NT5E (0.37) | NT5EALDH1A1CCNE1CDK2 | |
| SCHEMBL23994925 | 0.81 | NT5E (0.37) | NT5EALDH1A1CCNE1CDK2 | |
| SCHEMBL23993668 | 0.79 | NT5E (0.42) | NT5EALDH1A1CCNE1CDK2CCNE2 | |
| SCHEMBL25004844 | 0.79 | NT5E (0.42) | NT5EALDH1A1CCNE1CDK2CCNE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021222522-A1 | CD73 INHIBITING 2,4-DIOXOPYRIMIDINE COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2021-11-04 | — | — | WO | disclosed |